Neoplasm, hard and soft tissue, malignant

Note: A rating of 100 percent shall continue beyond the cessation of any surgical, radiation, antineoplastic chemotherapy or other therapeutic procedure. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of §3.105(e) of this chapter. If there has been no local recurrence or metastasis, rate on residuals such as loss of supporting structures (bone or teeth) and/or functional impairment due to scarring.

            [29 FR 6718, May 22, 1964, as amended at 43 FR 45362, Oct. 2, 1978; 59 FR 2530, Jan. 18, 1994; 82 FR 36083, Aug. 3, 2017]